ProShare Advisors LLC boosted its stake in shares of Balchem Co. (NASDAQ:BCPC – Free Report) by 7.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,037 shares of the basic materials company’s stock after purchasing an additional 5,401 shares during the quarter. ProShare Advisors LLC owned about 0.23% of Balchem worth $9,491,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in BCPC. Wasatch Advisors LP boosted its holdings in shares of Balchem by 27.0% during the first quarter. Wasatch Advisors LP now owns 2,069,516 shares of the basic materials company’s stock worth $261,752,000 after acquiring an additional 439,827 shares during the period. Norges Bank bought a new stake in shares of Balchem in the fourth quarter valued at about $40,469,000. Vanguard Group Inc. boosted its position in shares of Balchem by 7.3% in the third quarter. Vanguard Group Inc. now owns 3,862,027 shares of the basic materials company’s stock valued at $469,545,000 after acquiring an additional 261,534 shares during the period. Morgan Stanley boosted its position in shares of Balchem by 86.1% in the fourth quarter. Morgan Stanley now owns 491,506 shares of the basic materials company’s stock valued at $60,018,000 after acquiring an additional 227,360 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Balchem by 58.8% in the third quarter. Price T Rowe Associates Inc. MD now owns 345,020 shares of the basic materials company’s stock valued at $41,949,000 after acquiring an additional 127,686 shares during the period. Institutional investors own 87.91% of the company’s stock.
Insiders Place Their Bets
In other Balchem news, Director David B. Fischer sold 3,800 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $131.57, for a total transaction of $499,966.00. Following the completion of the sale, the director now directly owns 13,469 shares in the company, valued at $1,772,116.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.77% of the company’s stock.
Balchem Trading Up 0.8 %
Balchem (NASDAQ:BCPC – Get Free Report) last posted its quarterly earnings data on Friday, July 28th. The basic materials company reported $0.93 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.13. Balchem had a net margin of 10.58% and a return on equity of 10.43%. The business had revenue of $231.25 million during the quarter, compared to analysts’ expectations of $241.00 million. Analysts predict that Balchem Co. will post 3.5 EPS for the current fiscal year.
Analysts Set New Price Targets
BCPC has been the subject of a number of recent research reports. StockNews.com began coverage on shares of Balchem in a research report on Thursday, August 17th. They issued a “hold” rating for the company. HC Wainwright boosted their price target on Balchem from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, July 31st.
View Our Latest Report on Balchem
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
See Also
- Five stocks we like better than Balchem
- What Are Growth Stocks and Investing in Them
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- How to Invest in Social Media
- MarketBeat Week in Review – 9/11 – 9/15
- How to Invest in Apparel Stocks
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
